OCT 30, 2014 12:00 AM PDT

Cancer Study In Mice Brings Hope For Human Patients

A study conducted at the University of Chicago's Center for Personalized Therapeutics has shown remarkable results in eliminating human tumors that have been transplanted into mice. The new research, reported in the journal Science Translational Medicine, highlighted two drugs that were extremely effective and produced little or no side effects.

The drugs, OTS964 and its precursor OTS514, were given to mice that had been implanted with human cancer tumors. The drugs were given in two forms, intravenously and orally. Initially, the drugs showed toxicity to red and white blood cells, however once it was encased in liposomes, this toxicity was eliminated in the intravenous form and easily managed in the oral form.

The molecular target of this drug has been known for over a decade. TOPK (T-lymphocyte-activated killer cell-originated protein kinase) has always been associated with tumor growth. The protein is present in many kinds of human cancers, but the study looked at an especially aggressive lung tumor, LU-99. Researchers grew the tumors on the mice to 150 cubic millimeters and then injected the mice with OTS964, twice a week for three weeks. In five out of six of the mice, the tumors were completely eliminated. Even after the drug was stopped, the tumors continued to shrink.

The drug worked by preventing the tumor cells from dividing. TOPK is the agent that allows cancer cells to rapidly divide and spread disease. Without this protein, the cancer cells failed to divide and grow and essentially withered and died.

University of Chicago Professor of Medicine, Yusuke Nakamura, was excited by the results. "It is rare to see complete regression of tumors in a mouse model," he said. "Many drugs can repress the growth but it is uncommon to see them eradicated. This has rarely been reported."

Phase 1 clinical trials of the drug could begin as early as the fall of 2015
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed....
AUG 13, 2018
Videos
AUG 13, 2018
What does sunscreen look like with a UV camera?
  Have you ever wondered if there’s really a difference between SPF 30 and SPF 50? You’re not the only one. YouTuber Physics Girl set out...
AUG 21, 2018
Cancer
AUG 21, 2018
'Zombie' gene returns to life and kills cancer in elephants
Researchers have discovered a gene that can protect elephants from cancer. An estimated 17 percent of humans worldwide die from cancer, but less than five ...
SEP 04, 2018
Cancer
SEP 04, 2018
Metal beads that could help reduce chemotherapy side effects in brain tumor
Brain tumors are one of the most challenging types of cancers to treat. Only 1 in 7 patients will survive the disease, and those survivors will usually suffer from lots of side effects becaus...
OCT 30, 2018
Drug Discovery
OCT 30, 2018
Re-sensitizing Drug-resistant Human Tumor Cells
Understanding how cancer cells avoid death despite their DNA being damaged will create new strategies to enhance cancer cell killing through chemotherapy t...
DEC 11, 2018
Cancer
DEC 11, 2018
Biosensors developed that can detect cancer's metastatic ability
Researchers in University of California San Diego School of Medicine have developed a biosensor that can detect whether a cancer cell will spread in the future or not, which will help in deve...
Loading Comments...